North America - Nov/Dec 2019

  • USA: FDA medical device user fees for fiscal year 2020 increase by almost 6%

  • USA: Comments sought on possible exemption of powered wheelchair stretchers from pre-market notification

  • USA: Guidance documents issued on benefit-risk determinations

  • USA: Three guidance documents relating to de novo classifications are published

  • USA: Final guidance issued on Special 510(k) Program

  • USA: Guidance documents released with updates on HDE programme and HUD designations

  • USA: Guidance on performance tests and recommended labelling for coronary, peripheral, and neurovascular guidewires

  • USA: Labelling considerations for intravascular catheters, wires and delivery systems with lubricious coatings

  • USA: Updated 510(k) submission recommendations for metal expandable biliary stents and their delivery systems

  • USA: Streamlined submission process for investigational in vitro diagnostics used in oncology trials

  • USA: Draft and final guidance documents on digital health topics have been updated

  • USA: Four draft guidances and one final guidance issued in relation to the Safety and Performance Based Pathway

  • USA: Draft guidance on the Safer Technologies Program

  • USA: Providing regulatory submissions for devices in electronic format is subject of new draft guidance

  • USA: Guidance drafted on patient engagement in the design and conduct of clinical investigations

  • USA: Draft guidance issued on testing and labelling devices for safety in the magnetic resonance environment

  • USA: Guidance drafted to improve patient communication on breast implants

  • USA: Feedback sought on discussion paper concerning evaluation of benefits and risks of weight-loss devices

  • USA: CDRH publishes proposed guidance development lists for fiscal year 2020

  • USA: Modifications to the list of US FDA-recognised standards Click here for the full article on Global Regulatory Press. Contact us at

Recent Posts
  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle
  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle



Call us:

   : +65 6909 0396

   : +65 9067 1432


Email us:


© 2020 ARQon All Rights Reserved. 

  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle